Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle McKenzie

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot studyGrace E Macalino, Jennifer A Mitty, Lauri B Bazerman, et al.
Drug and Alcohol Dependence|March 10, 2018
Erratum to: A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release [Drug and Alcohol Dependence 184 (2018) 57-63]Lauren Brinkley-Rubinstein, Michelle McKenzie, Alexandria Macmadu, et al.
Journal of Substance Abuse Treatment|April 2, 2013
Initiation of buprenorphine during incarceration and retention in treatment upon releaseNickolas Zaller, Michelle McKenzie, Peter D Friedmann, et al.
Addictive Disorders & Their Treatment|November 29, 2011
An Adverse Reaction to Buprenorphine/Naloxone Induction in Prison: A Case ReportJosiah D Rich, Michelle McKenzie, Samuel Dickman, et al.
Substance Use & Misuse|December 21, 2023
"I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode IslandAlexandra B Collins, Eliana Kaplowitz, Parsa Bastani, et al.
Drug and Alcohol Dependence|December 15, 2018
Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site studyJennifer L Glick, Tricia Christensen, Ju Nyeong Park, et al.
Journal of Public Health Management and Practice : JPHMP|December 28, 2023
Differences in Substance Use and Harm Reduction Practices by Race and Ethnicity: Rhode Island Harm Reduction Surveillance System, 2021-2022McClaren Rodriguez, Michelle McKenzie, Haley McKee, et al.
Rhode Island Medical Journal (2013)|March 29, 2023
Preliminary findings from the Rhode Island Harm Reduction Surveillance System: January 2021-December 2022Emily M Ledingham, Michelle McKenzie, Haley McKee, et al.
Public Health Reports (Washington, D.C. : 1974)|March 10, 2026
Exploratory Analysis of the Characteristics Associated With the Use of Fentanyl Test Strips Among People Who Use Drugs in Rhode Island, 2021-2023Menaka Naidu, Jaejoon Shin, Kristen St John, et al.
Journal of Addictive Diseases|September 28, 2005
Linkage with methadone treatment upon release from incarceration: a promising opportunityJosiah D Rich, Michelle McKenzie, David C Shield, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot studyGrace E Macalino, Jennifer A Mitty, Lauri B Bazerman, et al.
Drug and Alcohol Dependence|March 10, 2018
Erratum to: A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release [Drug and Alcohol Dependence 184 (2018) 57-63]Lauren Brinkley-Rubinstein, Michelle McKenzie, Alexandria Macmadu, et al.
Journal of Substance Abuse Treatment|April 2, 2013
Initiation of buprenorphine during incarceration and retention in treatment upon releaseNickolas Zaller, Michelle McKenzie, Peter D Friedmann, et al.
Addictive Disorders & Their Treatment|November 29, 2011
An Adverse Reaction to Buprenorphine/Naloxone Induction in Prison: A Case ReportJosiah D Rich, Michelle McKenzie, Samuel Dickman, et al.
Substance Use & Misuse|December 21, 2023
"I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode IslandAlexandra B Collins, Eliana Kaplowitz, Parsa Bastani, et al.
Drug and Alcohol Dependence|December 15, 2018
Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site studyJennifer L Glick, Tricia Christensen, Ju Nyeong Park, et al.
Journal of Public Health Management and Practice : JPHMP|December 28, 2023
Differences in Substance Use and Harm Reduction Practices by Race and Ethnicity: Rhode Island Harm Reduction Surveillance System, 2021-2022McClaren Rodriguez, Michelle McKenzie, Haley McKee, et al.
Rhode Island Medical Journal (2013)|March 29, 2023
Preliminary findings from the Rhode Island Harm Reduction Surveillance System: January 2021-December 2022Emily M Ledingham, Michelle McKenzie, Haley McKee, et al.
Public Health Reports (Washington, D.C. : 1974)|March 10, 2026
Exploratory Analysis of the Characteristics Associated With the Use of Fentanyl Test Strips Among People Who Use Drugs in Rhode Island, 2021-2023Menaka Naidu, Jaejoon Shin, Kristen St John, et al.
Journal of Addictive Diseases|September 28, 2005
Linkage with methadone treatment upon release from incarceration: a promising opportunityJosiah D Rich, Michelle McKenzie, David C Shield, et al.
Pageof 6